Overview

Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes

Status:
Completed
Trial end date:
2019-02-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of the study drug ZGN-1061 in participants with type 2 diabetes.
Phase:
Phase 2
Details
Lead Sponsor:
Zafgen, Inc.
Treatments:
ZGN-1061